David Dadiomov, Stephanie Shafer & Stacia Woodcock – Advanced Psychopharmacology Online Course: Anxiety, Depression, Bipolar, & More!

*** Proof of Product ***

Exploring the Essential Features of “David Dadiomov, Stephanie Shafer & Stacia Woodcock – Advanced Psychopharmacology Online Course: Anxiety, Depression, Bipolar, & More!”

Safe and appropriate prescribing is a complex and challenging task. As a clinician, you do everything you can to prescribe with perfection for your patients experiencing mental health symptoms. After all, patients depend on you to do just that.

Maintaining an up-to-date knowledge base is key. However, it can feel overwhelming to incorporate the very latest evidence-based guidelines, especially when you are responsible for a multitude of clinical diagnoses. From contraindications, drug interactions, adverse effects, cost considerations and appropriate monitoring, there is significant information required to go beyond proficiency to highly skilled prescribing practices.

You need to apply critical thinking through each unique patient encounter. With this Advanced Psychopharmacology online course, you will transform patient outcomes. Highlights you can expect:

✔  3 steps to successful antidepressant prescribing
✔  Appropriate course of action for a warning of serotonin syndrome
✔  Augmentation strategies when the initial therapy doesn’t elicit a full response
✔  Safe tapering guidelines for benzodiazepines
✔  Natural products for anxiety: Updates on FDA approvals and labeling
✔  Lithium formulation and therapeutic drug monitoring
✔  Apply psychopharmacology to the treatment of addiction disorders (opioids, alcohol, stimulants)
✔  Treatment resistant psychiatric conditions, complex diagnoses, and more
✔  How neurotransmitters and medications impact trauma symptoms
✔  And explore the evolving world of clinical psychedelic uses

Act now… and you’ll join clinicians across the country to confidently select the most appropriate and beneficial psychotropic drug therapies for your patients!

Evidence Based Updates From:

• Journal of Clinical Pharmacology
• Journal of Pharmacy and Pharmacology
• Journal of Internal Medicine
• Journal of American Medical Association
• Journal of Abnormal Psychology
• Journal of Psychiatric Research
• Journal of Psychopharmacology
• Journal of American Medical Association Psychiatry
• Journal of Cannabis Therapeutics

What’s Inside

Advanced Applications in Psychopharmacology

David Dadiomov, PharmD, BCPP

You’ll get the knowledge you need to know so you can answer your patients’ questions, manage complex side effects, and prescribe with proficiency for depression, anxiety, bipolar, and more.

Gain easy-to-apply strategies on high-risk prescription opioid use, therapeutic drug monitoring, substance intoxication and withdrawal, and treatment-resistant psychiatric conditions. Use the comprehensive guide for medication and non-medication interventions to quickly respond to signs of substance-use-related emergencies and know how SUDs impact various health conditions.

Best of all, you’ll get access to enlightening case studies you can’t get anywhere else and a comprehensive reference guide to immediately put to use in your work setting!

Differential Diagnosis in Mental Health Conditions

• Substance intoxication or withdrawal
• How to screen and rule out other diagnoses

Practical Psychopharmacology for Depression Treatment

• SSRIs
• SNRIs
• Atypical Antidepressants
• New treatments
• Adverse effects
  • Adverse effects that are applicable to the whole class
  • Specific adverse effect management
• Efficacy of antidepressants and time course

Practical Psychopharmacology for Anxiety Treatment

• SSRIs
• SNRIs
• Benzodiazepines
• Buspirone
• Hydroxyzine

Practical Psychopharmacology for Schizophrenia Treatment

• Antipsychotics
  • 1st generation antipsychotics
  • 2nd generation antipsychotics
  • Clozapine

• Therapeutic drug monitoring
• Black box warnings
• Long-acting injectable antipsychotics
• Management of acute agitation

Practical Psychopharmacology for Bipolar Disorder Treatment

• Mood stabilizers
  • Lithium
  • Valproic acid
  • Lamotrigine
  • Carbamazepine
  • Second-generation antipsychotics

• Therapeutic drug monitoring
• Black box warnings

Disparities in Addiction Treatment for Patients

• Alcohol
• Opioids
• Stimulants
• Nicotine

Harm Reduction Practices

• Needle exchange
• Naloxone distribution
• Overdose education
• Fentanyl test strips

Psychedelic Therapeutic Evidence for Treatment of Mental Health Disorders

• Psilocybin
  • Depression
  • Anxiety
  • Addiction

• DMT
• LSD
• MDMA
• Ketamine

Safety Considerations for Psychedelics

• Drug interactions impacting safety
  • Classic psychedelics and antidepressants (SSRIs and SNRIs)
• • • Becker 2022
    • Introduction to serotonin toxicity

• Drug interactions that reduce efficacy
• Adverse effects of the different agents

Microdosing strategies/evidence

Integration strategies

• Pre-trip preparations
• Other therapy strategies

FREE BONUSES! 
 
Psychopharmacology of Trauma for Mental Health & Healthcare Professionals

Stephanie Shafer, RN, MSN, ANP-BC, PMHNP-BC

You’ve seen patients come in with a laundry list of medications and multiple diagnoses — PTSD, depression, anxiety, and more. Knowing the in and outs of how trauma and comorbid mental health problems affect the brain and are then impacted by medication is essential to your work.

• Expertise in commonly prescribed psychotropic medications, including adverse effects, applications, interactions, and the brain pathways used
• Investigate how neurotransmitters and medications interact and impact trauma symptoms
• Assess non-pharmaceutical interventions in treatment planning

Cannabis Pharmacology Updates: From a Clinical Cannabis Pharmacist

Stacia Woodcock, PharmD

This session provides a comprehensive look at the clinical aspects of cannabis as medicine, from a Clinical Cannabis Pharmacist. Evaluate patients for appropriateness of cannabis therapy based on potential contraindications, precautions, and drug/drug interactions.

• Cannabis addiction, withdrawal, and cannabis use disorder
• Adverse effects, interactions, & contraindications
• Cannabis dosing & dosage forms
• Pharmacokinetics of phytocannabinoids
• Cannabis pharmacogenomics

Meet Your Experts

David Dadiomov, PharmD, BCPP, is a clinical assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy. In this role, he has worked to establish novel clinical pharmacy services for patients experiencing homelessness, incarcerated patients, and those with severe mental illness and addiction disorders. As a board-certified clinical psychiatric pharmacist, Dr. Dadiomov works both in direct patient care and allied health settings, to treat high-risk patients. He has led, co-led, and conducted extensive research on opioid use disorders among vulnerable populations, high-risk prescription opioid use, therapeutic drug monitoring, and treatment-resistant psychiatric conditions. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching, and innovation. He has presented, authored, and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.

Stephanie Shafer, MSN, ANP-BC, PMHNP-BC, has accumulated over 14 years dedicated to serving as a nurse practitioner, with work experience in psychiatry, primary care, and surgery. Her educational background includes graduate studies at UCLA, followed by a specialized post-master’s degree in psychiatric mental health from The Johns Hopkins University. For a decade, Stephanie has provided outpatient psychiatry services, particularly specializing in anxiety, depression, bipolar disorder, and trauma treatment. Her expertise in this domain has extended to national speaking engagements. She is also the founder of Neurobehavioral Health and Wellness, which is a private mental health clinic in Lansing, Michigan where Stephanie collaborates with Dr. Brandon Francis, MD. The practice focuses on integrative psychiatry, TBI management, and approaches to overall health and well-being. 

Stacia Woodcock, PharmD, and clinical cannabis pharmacist in New York City. After receiving her PharmD from the University of Kentucky, Dr. Woodcock served as a clinical specialty pharmacist with an emphasis in medication therapy management, as well as fertility and women’s issues. Dr. Woodcock became a dedicated cannabis clinician after seeing first-hand the ability of medical cannabis to reduce the polypharmacy rampant in today’s society and significantly improve patient outcomes with minimal side effects. She delights in using her clinical expertise to help educate practitioners, patients, and communities in an effort to remove the pervasive stigma surrounding cannabis as medicine. She has been a featured medical expert on The Dr. Oz Show and the Rachael Ray Show, among others, and is a devoted clinical advocate in the medical cannabis space.

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/